ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
59,052.13
1.40%
S&P 500
5,038.65
0.40%
Dow Jones
38,076.75
0.46%
US Dollar vs Yen
154.367
-0.87%
Brent Oil
83.265
-0.33%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Tarsus Pharmaceuticals Inc (TARS)

  7. Tarsus Pharmaceuticals Inc (TARS) ニュース

TARS Tarsus Pharmaceuticals Inc

32.68
0.19 (0.58%)
最終更新日： 23:45:02
15分遅延
名称 銘柄コード 市場 種別
Tarsus Pharmaceuticals Inc TARS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.19 0.58% 32.68 23:45:02
始値 安値 高値 終値 前日終値
32.31 32.02 33.34 32.49
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0206:00GLOBETarsus to Report First Quarter 2024 Financial Results on..
2024/4/2321:30GLOBETarsus Strengthens Financial Position and Refinances..
2024/3/1206:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1206:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1206:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/1206:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0606:30GLOBETarsus to Participate at Upcoming Investor Conferences
2024/3/0606:09EDGAR2Form 8-K - Current report
2024/3/0522:30GLOBETarsus Introduces “Mite Party” Campaign for XDEMVY®..
2024/3/0207:26EDGAR2Form 8-K - Current report
2024/3/0207:17EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0114:07GLOBETarsus Announces Pricing of $100.0 Million Public Offering
2024/3/0107:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/3/0106:37GLOBETarsus Announces Proposed $100.0 Million Public Offering
2024/3/0106:32EDGAR2Form S-3ASR - Automatic shelf registration statement of..
2024/2/2806:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/2806:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2720:00GLOBETarsus Reports Strong Fourth Quarter and Full-Year 2023..
2024/2/2222:00GLOBETarsus Announces Positive Topline Results from Carpo, a..
2024/2/2107:00GLOBETarsus to Report Fourth Quarter and Full Year 2023 Financial..
2024/2/0107:00GLOBETarsus to Participate in Fireside Chat at the Sixth Annual..
2024/1/3106:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2307:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/1906:30EDGAR2Form 8-K - Current report
2024/1/0823:00EDGAR2Form 8-K - Current report
2023/12/3007:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2806:23EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2307:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:49EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2008:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1123:01EDGAR2Form 8-K - Current report
2023/12/1122:00GLOBETarsus Announces Positive Topline Results from the Ersa..
2023/12/0206:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0206:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0106:35EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0106:15EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2214:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1806:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1606:53EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1006:18EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1006:05EDGAR2Form 8-K - Current report
2023/11/1006:05GLOBETarsus Reports Third Quarter 2023 Financial Results and..
2023/11/1006:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0207:35GLOBETarsus to Report Third Quarter 2023 Financial Results on..
2023/10/2105:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1905:26EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/2105:30EDGAR2Form 144 - Report of proposed sale of securities
2023/9/0621:00GLOBETarsus to Ring Nasdaq Stock Market Closing Bell in..
2023/8/3105:30GLOBETarsus to Present at Upcoming Investor Conferences

最近閲覧した銘柄

NASDAQ
TARS
Tarsus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有